Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.05
    +1.70 (+2.09%)
     
  • Gold

    2,243.00
    +30.30 (+1.37%)
     
  • Silver

    24.98
    +0.23 (+0.92%)
     
  • EUR/USD

    1.0792
    -0.0037 (-0.35%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2625
    -0.0013 (-0.10%)
     
  • USD/JPY

    151.3660
    +0.1200 (+0.08%)
     
  • Bitcoin USD

    70,740.59
    +1,829.38 (+2.65%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Warren Buffett and Charlie Munger just destroyed Valeant at Berkshire's annual meeting

valeant ackman pearson
valeant ackman pearson

(AP Images/Manuel Balce Ceneta)
From left, Valeant's outgoing CEO, J. Michael Pearson; former chief financial officer Howard Schiller; and billionaire investor William Ackman, whose hedge fund holds a large stake in Valeant and controls two seats on its board of directors, are sworn in on Capitol Hill in Washington, Wednesday, April 27, 2016, prior to testifying before the Senate Special Committee on Aging hearing on drastic price hikes by Valeant and a handful of other drugmakers that have stoked outrage from patients, physicians and politicians nationwide.

Warren Buffett is not a fan of Valeant Pharmaceuticals.

And he never was.

At Berkshire Hathaway's annual meeting on Saturday, Buffett expressed disappointment over the direction of the company and called it a "Wall Street scheme."

"In my view, the business model of Valeant was enormously flawed," said Buffett.

Buffett's partner Charlie Munger, who last year made headlines with comments about the company, also chimed in.

"Valeant, of course, was a sewer," said Munger, adding that the directors deserve "all the opprobrium they are getting."

Valeant has had a disastrous six months with scandals involving its practice of purchasing drug companies and then raising the prices on their products, a mess of a financial report tied to shady revenue reporting, and patient assistance programs that are being investigated in multiple states.

All of these problems have led to the removal of the company's top executive, an investigation by the US Senate, and a 70% decline in the company's stock price.

Buffett also said that he was approached by multiple people asking if he wanted to in Valeant and urging Buffett to meet former Valeant CEO Michael Pearson. Buffett said he declined to do either of those things, and was wary of the company from the start.

There were also some pointed words about management.

"If you're looking for a manager you want someone who is intelligent, energetic, and moral," said Buffett. "But if they don't have the last one, you don't want them to have the first two."

The question also asked about Sequoia Fund, a mutual fund Buffett has been associated with for some time that had accumulated a stake in Valeant. (One of Sequoia's founders, Bill Ruane, was a Buffett confidant from way back.)

Buffett said that it was unfortunate that Sequoia took such a large position in Valeant, saying the investment firm was "entranced" by Valeant's business model. Buffett also noted that the manager that selected the investment has since been fired.

NOW WATCH: FORMER GREEK FINANCE MINISTER: The single largest threat to the global economy



More From Business Insider

Advertisement